# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-24-028003
Filing Date
2024-03-29
Accepted
2024-03-29 16:32:10
Documents
89
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | ea0201465-10k_therapeu.htm iXBRL | 10-K | 1171833
2 | SUBSIDIARIES OF THE COMPANY | ea020146501ex21-1_therapeu.htm | EX-21.1 | 2097
3 | CONSENT OF BERKOWITZ POLLACK BRANT | ea020146501ex23-1_therapeu.htm | EX-23.1 | 2357
4 | CONSENT OF GRANT THORNTON LLP | ea020146501ex23-2_therapeu.htm | EX-23.2 | 1897
5 | CERTIFICATION | ea020146501ex31-1_therapeu.htm | EX-31.1 | 8987
6 | CERTIFICATION | ea020146501ex31-2_therapeu.htm | EX-31.2 | 8722
7 | CERTIFICATION | ea020146501ex32-1_therapeu.htm | EX-32.1 | 4328
8 | CERTIFICATION | ea020146501ex32-2_therapeu.htm | EX-32.2 | 3552
9 | THERAPEUTICSMD, INC. POLICY ON RECOUPMENT OF INCENTIVE COMPENSATION | ea020146501ex97-1_therapeu.htm | EX-97.1 | 20579
10 | GRAPHIC | image_001.jpg | GRAPHIC | 2338
| Complete submission text file | 0001213900-24-028003.txt |  | 7112905

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL SCHEMA FILE | txmd-20231231.xsd | EX-101.SCH | 79836
12 | XBRL CALCULATION FILE | txmd-20231231_cal.xml | EX-101.CAL | 68659
13 | XBRL DEFINITION FILE | txmd-20231231_def.xml | EX-101.DEF | 367764
14 | XBRL LABEL FILE | txmd-20231231_lab.xml | EX-101.LAB | 686429
15 | XBRL PRESENTATION FILE | txmd-20231231_pre.xml | EX-101.PRE | 367594
93 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0201465-10k_therapeu_htm.xml | XML | 739095

Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-00100 | Film No.: 24804473
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)